年代:1982 |
|
|
Volume 1 issue 1
|
|
1. |
Introduction |
|
Journal of Clinical Apheresis,
Volume 1,
Issue 1,
1982,
Page 1-1
C. Harold Mielke,
Preview
|
PDF (53KB)
|
|
ISSN:0733-2459
DOI:10.1002/jca.2920010102
出版商:John Wiley&Sons, Inc.
年代:1982
数据来源: WILEY
|
2. |
Removal of specific antibody in vivo by whole blood immunoadsorption: Preliminary results in dogs |
|
Journal of Clinical Apheresis,
Volume 1,
Issue 1,
1982,
Page 2-5
W. I. Bensinger,
C. D. Buckner,
D. A. Baker,
R. A. Clift,
E. D. Thomas,
Preview
|
PDF (295KB)
|
|
摘要:
AbstractEffective immunoadsorption for removal of anti‐red cell antibodies from plasma using affinity columns has been demonstrated. However, the requirement of a continuous‐flow centrifuge to separate plasma increases the cost and complexity of the procedure. We have adapted red cell antigen immunoadsorption columns for use with whole blood. Effective and specific removal of anti‐red cell antibodies was achieved in actively immunized
ISSN:0733-2459
DOI:10.1002/jca.2920010103
出版商:John Wiley&Sons, Inc.
年代:1982
数据来源: WILEY
|
3. |
Treatment of thrombotic thrombocytopenic purpura with plasma exchange, antiplatelet agents, corticosteroid, and plasma infusion: Mayo clinic experience |
|
Journal of Clinical Apheresis,
Volume 1,
Issue 1,
1982,
Page 6-13
Robert L. Breckenridge,
Lawrence A. Solberg,
Alvaro A. Pineda,
Robert M. Petitt,
Dilipkumar D. Dharkar,
Preview
|
PDF (664KB)
|
|
摘要:
AbstractTen patients with thrombocytopenia (TTP) were treated recently in our institution with plasma exchange (PE), steroids, and antiplatelet drugs. Additionally, fresh frozen plasma (FFP) was administered to nine patients, with folic acid given to eight patients.After 13 to 25 months of follow‐up, we found that four patients achieved and remained in remission after initial treatment. Three patients had four relapses, which developed while they were taking antiplatelet therapy, and which were treated successfully with FFP alone, or with PE in addition to FFP. Four patients suffered major neurological or renal damage during their presentation or initial treatment. One of these patients died during his initial hospitalization. Another patient died 7 months after initial treatment.After analyzing this experience, we have concluded that antiplatelet drugs or corticosteroid should be used as the sole initial treatment most cautiously. The relative importance of the exchange process, per se, versus plasma infusion cannot be inferred from our observations, but plasma exchange with FFP appears to have had a real impact on recover
ISSN:0733-2459
DOI:10.1002/jca.2920010104
出版商:John Wiley&Sons, Inc.
年代:1982
数据来源: WILEY
|
4. |
Use of lymphoplasmapheresis or plasmapheresis in the management of acute renal allograft rejection |
|
Journal of Clinical Apheresis,
Volume 1,
Issue 1,
1982,
Page 14-17
Steven Kleinman,
Marcus Nichols,
Franklin Strauss,
Dennis Goldfinger,
Preview
|
PDF (285KB)
|
|
摘要:
AbstractSeveral recent reports have documented the value of intensive plasmapheresis as an adjunct to standard immunosuppressive therapy for patients suffering acute renal allograft rejection. We have treated four rejection episodes in three patients with intensive plasmapheresis and two rejection episodes in two additional patients with intensive lymphoplasmapheresis. Five of six rejection episodes were reversed, and four of the five patients treated have retained functioning grafts for follow‐up periods ranging from 4 months to 3 years. Previous investigators have reported encouraging results using plasmapheresis, and we believe our experience supports the requirement for further controlled studies with this procedure. Moreover, we note that no previous work has been described with lymphoplasmapheresis and suggest that removal of lymphocytes, in addition to plasma, may further augment immunosuppression in the treatment of renal allograft rejectio
ISSN:0733-2459
DOI:10.1002/jca.2920010105
出版商:John Wiley&Sons, Inc.
年代:1982
数据来源: WILEY
|
5. |
Separation of platelet‐rich plasma by modified centrifugal elutriation |
|
Journal of Clinical Apheresis,
Volume 1,
Issue 1,
1982,
Page 18-24
Maxim D. Persidsky,
Nan‐Sing Ling,
Preview
|
PDF (636KB)
|
|
摘要:
AbstractThe Beckman centrifugal elutriation (CE) system is modified for the separation of platelet‐rich plasma (PRP) from human and rabbit blood. The Beckman separation chamber is found inadequate for this purpose, and a new chamber of conical shape has been developed. Optimal flow rate for separating PRP from whole blood with the new chamber of 11.3 ml capacity is 3.5 ml/min while centrifuging at 2500 rpm or 700g. Collection process takes about 4 minutes. This new process is based on the principle of centrifugal counterflow displacement and filtration, and is different from the CE process which is based on counterflow centrifugation and differential elution. About 90% of total platelets are recovered with this new process. The collected samples are free of leucocytes and contained only a few erythrocytes. Platelets collected by either differential centrifugation (DC) or new procedures are found to be similar in morphological characteristics, both being discoidal. Other characteristics such as aggregation response induced by ADP or epinephrine, serotonic‐14C secretion, and survival of autologous platelets in rabbits are also found to be similar. However, ATP release induced by ADP is consistently higher from platelets prepared by our procedure than from those prepared by the DC proced
ISSN:0733-2459
DOI:10.1002/jca.2920010106
出版商:John Wiley&Sons, Inc.
年代:1982
数据来源: WILEY
|
6. |
The historical development of automated hemapheresis |
|
Journal of Clinical Apheresis,
Volume 1,
Issue 1,
1982,
Page 25-32
Bruce L. Millward,
Gerald A. Hoeltge,
Preview
|
PDF (859KB)
|
|
摘要:
AbstractMany studies in the early twentieth century involved attempts to separate white blood cells from whole blood for further examination and experimentation as well as for the treatment of neutropenic patients. In the 1950s, the need to use blood and its derivatives efficiently produced the first apparatus to separate blood continuously in a closed system. The prototypes of present‐day continuous flow blood cell separators were developed in the 1960
ISSN:0733-2459
DOI:10.1002/jca.2920010107
出版商:John Wiley&Sons, Inc.
年代:1982
数据来源: WILEY
|
7. |
Review: Deficiencies in the neutrophil system of newborn infants, and the use of leukocyte transfusions in the treatment of neonatal sepsis |
|
Journal of Clinical Apheresis,
Volume 1,
Issue 1,
1982,
Page 33-41
Robert D. Christensen,
Harold S. Anstall,
Gerald Rothstein,
Preview
|
PDF (830KB)
|
|
摘要:
AbstractBacterial sepsis is a major cause of morbidity and mortality in the neonatal period. Deficiencies in neutrophil chemotaxis, phagocytosis, and bacterial killing have all been proposed as factors possibly responsible for this problem. In addition, the neutrophil storage pool, or all segmented neutrophils, band neutrophils, and meramyelocytes/kg body weight stored within the marrow, appears to be very small in neonates compared to that in adults, and when an infection develops in a neonate, neutrophil production from stem cells may be limited. In this paper we review the evidence for these neonatal neutrophil deficiencies and examine the animal and clinical studies which have tested leukocyte transfusion as a possible adjunctive therapeutic modality for sepsis neonatorum.
ISSN:0733-2459
DOI:10.1002/jca.2920010108
出版商:John Wiley&Sons, Inc.
年代:1982
数据来源: WILEY
|
8. |
Plasmapheresis in lupus nephritis with nephrotic syndrome: A long‐term followup |
|
Journal of Clinical Apheresis,
Volume 1,
Issue 1,
1982,
Page 42-45
Daniel J. Wallace,
Dennis Goldfinger,
Rodney Bluestone,
James R. Klinenberg,
Preview
|
PDF (329KB)
|
|
摘要:
AbstractLupus nephritis with nephrotic syndrome is one of the most serious complications of systemic lupus erythematosus. Six female patients with systemic lupus and nephrotic syndrome, refractory to immunosuppressive drug therapy, received 15–20 exchange plasmaphereses. One patient, treated concurrently with high‐dose steroids, showed temporary improvement, and five patients, treated concurrently with steroids and either cyclophosphamide or azathioprine, had long‐term remissions. Plasmapheresis is a promising therapeutic modality in cases of refractory lupus nephritis with nephrotic syn
ISSN:0733-2459
DOI:10.1002/jca.2920010109
出版商:John Wiley&Sons, Inc.
年代:1982
数据来源: WILEY
|
9. |
Childhood chronic relapsing polyneuropathy: Dramatic improvement following plasmapheresis |
|
Journal of Clinical Apheresis,
Volume 1,
Issue 1,
1982,
Page 46-49
R. Kevin Connor,
Fred A. Ziter,
Harold B. Anstall,
Preview
|
PDF (363KB)
|
|
摘要:
AbstractWe present clinical data on two boys with chronic relapsing polyneuropathy. Their recurrent episodes of weakness had produced marked disability which was unresponsive to continuous prednisone therapy. Plasmapheresis produced dramatic improvement in muscle strength and functional ability. The remissions induced have been sustained despite withdrawal of steroid therapy.
ISSN:0733-2459
DOI:10.1002/jca.2920010110
出版商:John Wiley&Sons, Inc.
年代:1982
数据来源: WILEY
|
10. |
National center for health care technology assessment of therapeutic apheresis for rheumatoid arthritis, 1981 |
|
Journal of Clinical Apheresis,
Volume 1,
Issue 1,
1982,
Page 50-54
Stephen P. Heyse,
Pierre R. Renault,
Seymour Perry,
Preview
|
PDF (501KB)
|
|
摘要:
AbstractThe National Center for Health Care Technology coordinated the Public Health Service's assessment of therapeutic apheresis for rheumatoid arthritis in response to the Health Care Financing Administration's request for advice regarding Medicare coverage of this rapidly emerging technology. The information considered included reports available in the medical literature (as of early 1981), advice from the National Institutes of Health and Food and Drug Administration, advice from the appropriate medical societies, as well as information submitted by interested parties in response to a notice published in the Federal Register announcing the assessment. Synthesis of this information provided the basis for concluding that therapeutic apheresis for rheumatoid arthritis was considered experimental with the possible exception of treatment for life‐threatening complications such as vasculitis, cryoglobulinemia, or hyperviscosity syndrom
ISSN:0733-2459
DOI:10.1002/jca.2920010111
出版商:John Wiley&Sons, Inc.
年代:1982
数据来源: WILEY
|
|